World's Best Scientists 2026 revealed!
Robert S. Wallis

Robert S. Wallis

D-Index & Metrics

Immunology

D-Index
70
Citations
16315
World Ranking
2430
National Ranking
10

Robert S. Wallis publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Robert S. Wallis sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 181 publications — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Robert S. Wallis D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Robert S. Wallis sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 70 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Robert S. Wallis is affiliated with the Aurum Institute in South Africa, specializing in research predominantly within the field of Medicine. Their scholarly work focuses extensively on Infectious Diseases, Epidemiology, and Pulmonary and Respiratory Medicine, with additional contributions to Surgery and Molecular Biology.

The scientist's research covers several key topics, including:

  • Tuberculosis Research and Epidemiology
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Infectious Diseases and Tuberculosis
  • Mycobacterium research and diagnosis
  • Pneumonia and Respiratory Infections
  • SARS-CoV-2 and COVID-19 Research

Robert S. Wallis has collaborated frequently with colleagues such as Gavin Churchyard, Pholo Maenetje, Salome Charalambous, Norbert Heinrich, and Stellah Mpagama.

They have contributed to several notable publication venues, including:

  • PLoS ONE
  • The International Journal of Tuberculosis and Lung Disease
  • Gates Open Research
  • SSRN Electronic Journal
  • The Lancet Respiratory Medicine

Among recent papers authored or co-authored by Robert S. Wallis are:

  • Host-directed immunotherapy of viral and bacterial infections: past, present and future, 2022, Nature reviews. Immunology
  • Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial, 2021, The Lancet Respiratory Medicine
  • Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae, 2021, The Lancet Global Health
  • Clinical standards for the assessment, management and rehabilitation of post-TB lung disease, 2021, The International Journal of Tuberculosis and Lung Disease
  • Post-tuberculosis lung health: perspectives from the First International Symposium, 2020, The International Journal of Tuberculosis and Lung Disease

Best Publications

  • Granulomatous Infectious Diseases Associated with Tumor Necrosis Factor Antagonists

    R. S. Wallis;M. S. Broder;J. Y. Wong;M. E. Hanson

  • Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice

    Robert S Wallis;Madhukar Pai;Madhukar Pai;Dick Menzies;Dick Menzies;T Mark Doherty

  • The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement

    I. Solovic;M. Sester;J. J. Gomez-Reino;H. L. Rieder

  • High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

    Martin J Boeree;Norbert Heinrich;Rob Aarnoutse;Andreas H Diacon

  • Host-directed therapies for infectious diseases: current status, recent progress, and future prospects

    Alimuddin Zumla;Alimuddin Zumla;Martin Rao;Martin Rao;Robert S Wallis;Stefan H E Kaufmann

  • Depressed T-Cell Interferon-γ Responses in Pulmonary Tuberculosis: Analysis of Underlying Mechanisms and Modulation with Therapy

    Christina S. Hirsch;Zahra Toossi;Catherine Othieno;John L Johnson

  • Tumour necrosis factor antagonists: structure, function, and tuberculosis risks.

    Robert S Wallis;Robert S Wallis

  • Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection

    Jason D. Simmons;Catherine Marie Stein;Chetan Seshadri;Monica Campo

  • Advancing host-directed therapy for tuberculosis

    Robert S. Wallis;Richard Hafner

  • Biomarkers for tuberculosis disease activity, cure, and relapse

    Robert S. Wallis;T. Mark Doherty;Phillip Onyebujoh;Mahnaz Vahedi

  • Tuberculosis—advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers

    Robert S Wallis;Markus Maeurer;Peter Mwaba;Jeremiah Chakaya

  • Tuberculosis biomarkers discovery: developments, needs, and challenges

    Robert S Wallis;Robert S Wallis;Robert S Wallis;Peter Kim;Stewart Cole;Debra Hanna

  • Host-directed immunotherapy of viral and bacterial infections: past, present and future

    Unknown

  • A study of the safety immunology virology and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis.

    Robert S. Wallis;Peter Kyambadde;John L. Johnson;Libby Horter

  • Granulomatous Infections Due to Tumor Necrosis Factor Blockade: Correction

    Robert S. Wallis;Michael Broder;John Wong;David Beenhouwer

  • Tumor Necrosis Factor Antagonists: Different Kinetics and/or Mechanisms of Action May Explain Differences in the Risk for Developing Granulomatous Infection

    Daniel E. Furst;Robert Wallis;Michael Broder;David O. Beenhouwer

  • Tumor-Necrosis-Factor Blockers: Differential Effects on Mycobacterial Immunity

    Oluwabunmi Y. Saliu;Carolina Sofer;Dana S. Stein;Stephan K. Schwander

  • Reactivation of latent granulomatous infections by infliximab

    Robert S. Wallis;Michael Broder;John Wong;Albert Lee

  • Human immune response to Mycobacterium tuberculosis antigens.

    D V Havlir;R S Wallis;W H Boom;T M Daniel

  • Induction of interleukin 1 and tumor necrosis factor by mycobacterial proteins: the monocyte western blot

    R S Wallis;M Amir-Tahmasseb;J J Ellner

  • Therapeutic Use of Infliximab in Tuberculosis to Control Severe Paradoxical Reaction of the Brain and Lymph Nodes

    Timothy K. Blackmore;Laurens Manning;William J. Taylor;Robert S. Wallis

Frequent Co-Authors

Jerrold J. Ellner
Jerrold J. Ellner Rutgers, The State University of New Jersey
John L. Johnson
John L. Johnson Case Western Reserve University
Gavin J. Churchyard
Gavin J. Churchyard Aurum Institute
Alimuddin Zumla
Alimuddin Zumla University College London
Markus Maeurer
Markus Maeurer Champalimaud Foundation
Michael Hoelscher
Michael Hoelscher Ludwig-Maximilians-Universität München
T. Mark Doherty
T. Mark Doherty Danish Institute for Study Abroad
Beate Kampmann
Beate Kampmann Charité - University Medicine Berlin
Michael M. Lederman
Michael M. Lederman Case Western Reserve University
Hardy Kornfeld
Hardy Kornfeld University of Massachusetts Chan Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare degrees online can broaden career opportunities. Nursing programs often serve as practical complements, especially roles focused on patient care and clinical treatment of immune-related conditions.

Many aspiring nurses begin by enrolling in accredited LPN programs easy to get into, which provide foundational training and a fast track into the healthcare field. These programs are ideal for those looking to build experience while continuing their education.

Advancement often comes through more specialized studies like nurse practitioner degrees. The easiest NP programs to get into allow students to gain advanced clinical skills and expand their scope of practice, including immunology-focused patient care.

For those interested in mental health and immunological implications on psychiatric conditions, pursuing a Psychiatric Mental Health Nurse Practitioner (PMHNP) degree is an excellent option. The top online PMHNP programs offer strong clinical placement rates to ensure hands-on experience.

Additionally, cost-conscious students can find quality education through cheapest psychiatric nurse practitioner programs that deliver value without compromising on accreditation or clinical opportunities.

By combining immunology studies with accessible nursing pathways, students can tailor careers that blend research, clinical expertise, and patient-centered care in innovative healthcare environments.

Best Scientists Citing Robert S. Wallis

Trending Scientists

Recently Published Articles